全球犬異位性皮膚炎藥物市場按藥物類別、給藥途徑、劑型、分銷管道和地區分類

Canine Atopic Dermatitis Treatment Drugs Market, By Drug Class, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球犬異位性皮膚炎治療市場規模估計為 16.485 億美元，預計到 2032 年將達到 32.763 億美元，2025 年至 2032 年的複合年成長率為 10.3%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	16.485億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	10.30％	2032 年價值預測	32.763億美元

圖。犬異位性皮膚炎治療市場佔有率（%），按地區，2025 年

犬異位性皮膚炎是寵物狗的慢性皮膚病。其特徵是皮膚發炎和感染。在過去的幾十年裡，寵物狗中異位性皮膚炎的盛行率增加。其確切病因尚不清楚，但據認為與遺傳、環境因素以及免疫系統對通常無害的物質的過度反應有關。患有異位性皮膚炎的狗狗會出現嚴重的搔癢、發炎和皮膚病變，讓它們非常不舒服。傳統上，人們使用抗組織胺和皮質類固醇來控制症狀。然而，這些藥物不能治癒疾病，長期使用可能會引起副作用。因此，需要安全有效的治療方法來緩解症狀並改善病情。一些製藥公司正在投資研發生物目標、免疫調節劑和其他新型治療方法。

市場動態：

全球犬異位性皮膚炎藥物市場受到寵物主人數量增加、研發活動活性化、犬異位性皮膚炎盛行率上升以及新產品推出等因素的推動。近年來，該市場核准並推出多種新藥，擴大了治療選擇。然而，新藥的高昂治療費用是一個障礙。市場參與企業將看到尚未開發的新興市場的成長機會和先進治療方法的進一步機會。

本研究的主要特點

本報告對全球犬異位性皮膚炎治療市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和復合年成長率。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球犬異位性皮膚炎治療藥物市場的主要企業簡介是根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出的。
本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球犬異位性皮膚炎治療藥物市場迎合了該行業的各種相關人員，例如投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球犬異位性皮膚炎治療市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,648.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.30%	2032 Value Projection:	USD 3,276.3 Mn

Canine atopic dermatitis is a chronic skin condition observed in domestic dogs. It is characterized by inflammation and infections of the skin. The prevalence of atopic dermatitis has been increasing among pet dogs over the past few decades. The exact causes are unknown, but it is believed to involve genetic and environmental factors that cause the immune system to overreact to substances that are normally harmless. Dogs with atopic dermatitis experience severe itching, inflammation, and skin lesions that lead to discomfort. Antihistamines and corticosteroids have traditionally been used to manage the symptoms. However, they do not cure the condition and long-term use can cause side effects. Therefore, there is a need for safe and effective treatment drugs that can relieve symptoms and modify the disease. Several pharmaceutical companies are investing in research and developing targeted biologics, immunomodulators, and other novel treatment approaches.

Market Dynamics:

The global canine atopic dermatitis treatment drugs market is driven by factors such as rising pet ownership, rising research and development activities, and increasing prevalence of canine atopic dermatitis, and new product launches. The market has witnessed the approval and launch of several new drugs in recent years which has expanded the treatment options available. However, high treatment costs associated with novel drugs is a restraint. The market players have opportunities for growth in untapped emerging markets and further development of advanced therapeutics.

Key Features of the Study:

This report provides an in-depth analysis of the global canine atopic dermatitis treatment drugs market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global canine atopic dermatitis treatment drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Bioiberica S.A.U, Dechra Pharmaceuticals PLC, Elanco, NIPPON ZENYAKU KOGYO CO., LTD, Vimian, TORAY INDUSTRIES, INC., Zoetis, Virbac, Ceva, Bimeda, Inc., Vivaldis, VetriMax Veterinary Products, Vetoquinol, and Royal Canin North America.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global canine atopic dermatitis treatment drugs market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global canine atopic dermatitis treatment drugs market.

Detailed Segmentation-

Drug Class:
- Janus Kinase Inhibitors
- Antihistamines
- Monoclonal Antibodies
- Antibiotics
- Allergic Immunotherapy/Desensitization Therapy
- Others
Route of Administration:
- Injectable
- Oral
- Topical
Dosage Form:
- Tablets
- Creams
- Spray
- Others
Distribution Channel:
- Online
- Offline
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bioiberica S.A.U
- Dechra Pharmaceuticals PLC
- Elanco
- NIPPON ZENYAKU KOGYO CO., LTD
- Vimian
- TORAY INDUSTRIES, INC.
- Zoetis
- Virbac
- Ceva
- Bimeda, Inc.
- Vivaldis
- VetriMax Veterinary Products
- Vetoquinol
- Royal Canin North America

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Brand and Pricing Analysis
Regulatory Scenario
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Canine Atopic Dermatitis Treatment Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Canine Atopic Dermatitis Treatment Drugs Market, By Drug Class, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Janus Kinase Inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Antihistamines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Allergic Immunotherapy/Desensitization Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Canine Atopic Dermatitis Treatment Drugs Market, By Route of Administration, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Canine Atopic Dermatitis Treatment Drugs Market, By Dosage Form, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Creams
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Canine Atopic Dermatitis Treatment Drugs Market, By Distribution Channel, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Online
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Offline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Canine Atopic Dermatitis Treatment Drugs Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

Company Profiles
- Bioiberica S.A.U
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dechra Pharmaceuticals PLC
- Elanco
- NIPPON ZENYAKU KOGYO CO., LTD
- Vimian
- TORAY INDUSTRIES, INC.
- Zoetis
- Virbac
- Ceva
- Bimeda, Inc.
- Vivaldis
- VetriMax Veterinary Products
- Vetoquinol
- Royal Canin North America